ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia

Gregory MA, D’Alessandro A, Alvarez-Calderon F, Kim J, et al. ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia. Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):E6669-E6678. Epub 2016 Oct 10. DOI:10.1073/pnas.1603876113

Date

BioLife Solutions Symbol

This website uses cookies to ensure you get the best experience on our website.